The fru 2 metabolic operon of Streptococcus agalactiae encodes the phosphoenolpyruvate:carbohydrate phosphotransferase system (PTS) enzyme II complex Fru 2 (EIIB . We propose a model of regulation of fru 2 depending on the presence of an activatory carbohydrate in the growth medium.
Summary
The fru 2 metabolic operon of Streptococcus agalactiae encodes the phosphoenolpyruvate:carbohydrate phosphotransferase system (PTS) enzyme II complex Fru 2 (EIIB Fru2 , EIIA
Fru2
, and EIIC Fru2 ); Fru 2 R, a transcriptional activator with PTS regulatory domains (PRDs); a D-allulose-6-phosphate 3-epimerase; a transaldolase; and a transketolase. We showed that the transcription of fru 2 is induced during the stationary phase of growth in complex media and during incubation in human cerebrospinal or amniotic fluids. D-allose and D- ribose are environmental signals governing this induction. PTS Fru2 is involved in the activation of the fru 2 promoter, and the histidine-67 of EIIA Fru2 and the cysteine-9 of EIIB Fru2 are important for this function.
The activation of fru 2 is also controlled by Fru 2 R. The histidine-243 in the PRD 1 domain, the histidine-323 in the PRD 2 domain, the cysteine-400 in the EIIB-like domain, and the histidine-549 in the EIIA-like domain are important for the function of Fru 2 R. Fru 2 R binds to a DNA region containing palindromic sequences upstream of the identified transcriptional start site. EIIB Fru2 interacts physically with the C-terminal part of
Introduction
Streptococcus agalactiae, also referred as group B Streptococcus, is an opportunistic pathogenic bacterium with a broad host range (Evans et al., 2008; Pereira et al., 2010) . Although it was first recognized as a causative agent of bovine mastitis, it also infects or colonizes humans and other animal species, such as fishes, aquatic mammals, horses and dogs (Evans et al., 2008; Godoy et al., 2013) . In human, S. agalactiae colonizes the lower digestive and urogenital tracts of healthy people. It can be isolated from the genitourinary and gastrointestinal tracts of up to 35% of healthy adults (Bliss et al., 2002; Melin and Efstratiou, 2013) . Besides its ability to develop in these tracts, S. agalactiae has also the capability to colonize the throat or the oral and nasopharyngeal mucosa, and to infect the blood, the mammary gland, or the amniotic and cerebrospinal fluids. In the last 40 years, S. agalactiae has been one of the most common bacteria responsible for maternal and neonatal infections (Schuchat, 1998; Tyrrell et al., 2000; Jones et al., 2006) . In addition, S. agalactiae is described as an emerging pathogen in immunocompromised nonpregnant adults and elderly persons. In immunocompromised adults, it is responsible for invasive infections, such as meningitis, endocarditis or soft tissue and osteoarticular infections (Farley, 2001; Edwards et al., 2005) . Finally, S. agalactiae was also identified as a food contaminant, mainly found in pastries and sea food products (van der MeeMarquet et al., 2009) . The aptitude of S. agalactiae to survive and develop in so many environments underlines its large capability of adaptation (van der Mee-Marquet et al., 2009; Richards et al., 2011; Fl echard and Gilot, 2014) . The sequencing of the genome of numerous strains of S. agalactiae revealed the broad capacity of this species to import carbon sources, which may reflect this capacity of adaptation. By example, the prototypic strain NEM316 expresses four sugar-specific ABC transporters, three glycerol permeases, one glycerol-phosphate permease and seventeen sugar-specific phosphoenolpyruvate-dependent phosphotransferase system (PTS) enzyme II complexes. These latter transporters were predicted to import either cellobiose, b-glucoside, trehalose, mannose, lactose, fructose, mannitol, N-acetylgalactosamine or glucose (Glaser et al., 2002) .
We previously reported that strains of some lineages of S. agalactiae possess an homolog of the PTS enzyme II complex Frz of extraintestinal pathogenic Escherichia coli (Patron et al., 2015) . The Frz system is involved in environmental sensing and regulation of the expression of adaptation and virulence genes in E. coli (Rouquet et al., 2009) . In S. agalactiae, this transporter of the fructose-mannitol family (EIIB Fru2 , EIIA Fru2 , and EIIC Fru2 ) is encoded by the fru 2 metabolic operon. The fru 2 operon also codes for a transcriptional activator with PTS regulatory domains (PRDs) of the FrzR/MtlR family (Fru 2 R), for a D-allulose-6-phosphate 3-epimerase, for a transaldolase, and for a transketolase (Fig. 1 ). The fru 2 operon is present on a genomic island that was acquired from a common ancestor before the divergence of a group of S. agalactiae strains comprising those of the clonal complexes 1, 7, 10, and 283 and of the sequence types 130 and 288. As S. agalactiae strains of clonal complexes 1 and 10 are frequently isolated from adults with invasive disease, we hypothesized that the Fru 2 system senses the environment to allow the bacterium to adapt to new conditions encountered during the infection of adults (Patron et al., 2015) . In a PTS pathway, an incoming sugar is translocated across the cytoplasmic membrane and concomitantly phosphorylated by the sugar specific transporter Enzyme II (EII) (Heravi et al., 2011) . The energy of the translocation is provided by a phosphorylation cascade from phosphoenolpyruvate (PEP), through the PTS Enzyme I, the heat stable histidine protein (HPr), the EIIA and EIIB subunits of the PTS transporter, and finally, the incoming sugar which is transported across the internal membrane via the integral membrane IIC subunit of the transporter (Deutscher et al., 2006; Heravi et al., 2011) . The expression of operons encoding components of the PTS is frequently regulated by antiterminators or transcriptional activators that contain PRDs (Deutscher et al., 2006) . In response to the availability of specific sugars, the PTS phosphorylates histidine or cysteine residues within these regulators to affect their function. The number and positions of phosphorylated histidines and cysteines vary among regulators with PRDs, and phosphorylation can positively or negatively affect protein activity (Stulke et al., 1998; van Tilbeurgh & Declerck, 2001; Greenberg et al., 2002; Joyet et al., 2010; Hondorp et al., 2013; Hammerstrom et al., 2015) . In addition to uptake and phosphorylation of the translocated sugar, the PTS is also involved in numerous regulatory activities: transport of non-PTS carbon sources, flagellar motility, switch between fermentative and respiratory metabolism, virulence, or hierarchical utilization of carbon sources (carbon catabolite repression, CCR) (O'Toole et al., 1997; King and O'Brian, 2001; Warner and Lolkema, 2003; Koo et al., 2004; Joyet et al., 2010; Heravi et al., 2011) .
In this work, we analyzed the regulation mechanism of the fru 2 operon by (i) localizing its transcriptional promoter and identifying its inductors (ii) determining the DNA binding region of the Fru 2 R regulator, (iii) identifying histidine or cysteine residues affecting the 
Results
Complex growth media and human cerebrospinal or amniotic fluids induce the activation of the fru 2 operon
To identify growth conditions and physiological environments inducing the fru 2 operon, we cloned the intergenic region upstream of fru 2 (fru 2 IR 540 , Fig. 1 ) or the 317 bp right end of this intergenic region (fru 2 IR
317
, Fig. 1 ) in the promoter probe vector pTCV-lacZ, in front of a gene coding for b-galactosidase. S. agalactiae strain A909 was transformed by these constructions and plated on complex media (TH-agar or BHI-agar) and on chemically defined media (CDM-agar with 30 mM D-mannose or CDM-agar with 30 mM D-glucose) containing X-Gal. On both complex media but not in the two defined media, bacteria colored in blue after 48 h of growth, indicating the presence of activable promoter(s) in these regions (Table 1 , data not shown). We then compared the bgalactosidase activity produced by A909 (pTCVfru 2 IR 540 ::lacZ) and A909 (pTCV-fru 2 IR 317 ::lacZ) during growth in TH broth. A b-galactosidase activity was induced by both constructions during the late stationary phase of growth, only ( Fig. 2A and B) . As similar activities were induced by the entire intergenic region or by its right end only, it is probable that no promoter(s) active during growth in complex media is present on the 223 bp left end of the intergenic region. We then studied the activity of the fru 2 promoter in human amniotic and cerebrospinal fluids, two biological fluids infectable by S. agalactiae. For that aim, we first cultured strain A909 (pTCV-fru 2 IR 317 ::lacZ) on agar plates containing amniotic or cerebrospinal fluids supplemented with X-Gal and a chemically defined medium without any carbohydrate. After 48 h of incubation, a bgalactosidase activity was visible on both media (data not shown). To quantify this activation, strain A909 (pTCV-fru 2 IR 317 ::lacZ) was incubated during 6-48 h in a chemically defined medium containing cerebrospinal or amniotic fluids. Although strain A909 mainly survived in these media, b-galactosidase activities were again induced by both human fluids, as soon as after 6 h of incubation (Fig. 3) .
The above results suggest that the activation of the fru 2 promoter depends on the presence of a carbohydrate being part of complex media and of human cerebrospinal or amniotic fluids. ::lacZ) was cultured during 48 h on various solid defined media (*, media containing these sugars contains also 15 mM D-glucose). The importance of the bgalactosidase activity was estimated by the intensity of the blue coloration of the bacterial colonies. 2, no activity; 1, low activity; 11, moderate activity; 111, high activity. Growth (OD 600 nm ) Time (hours) Fig. 2 . Activation of the fru 2 operon promoter in Todd Hewitt broth during the late stationary phase of growth. The entire intergenic region upstream of fru 2 (A) or its 317 bp right end (B) was cloned upstream of a b-galactosidase gene in the promoter probe plasmid pTCV-lacZ. S. agalactiae strain A909 was transformed by these constructions and grown in TH at 378C without agitation. These cultures were measured at OD 600 nm and growth curves were traced. After 4 h, 7 h, 24 h, 32 h, or 48 h of growth bacteria were harvested and the b-galactosidase activity was measured. Results are presented as means 6 standard deviations of three independent cultures.
Identification of carbohydrate inductors of the fru 2 operon
In view of identifying carbohydrate inductors of the fru 2 operon, we first tried to connect all the proteins encoded by the fru 2 operon in a metabolic pathway (Fig. 4) .
The sak1758 gene is present in a single copy in strain A909. It codes for a D-allulose-6-phosphate 3-epimerase. This enzyme allows the transformation of D-allulose-6-phosphate into D-fructose-6-phosphate. D-fructose-6-phosphate could be taken in charge by both the SAK1757 transaldolase and by the SAK1756 transketolase, and enter into the non-oxidative branch of the pentose phosphate pathway. Homologs of these two latter enzymes are also coded by the A909 genome (SAK1756 (Sorensen and Hove-Jensen, 1996; Kim et al., 1997; Poulsen et al., 1999) . The LacA (SAK1890) and LacB (SAK1889) subunits of the S. agalactiae galactose-6-phosphate isomerase possess 49% and 51% similar amino acids with the ribose-5-phosphate isomerase B (RpiB) of E. coli respectively. Although RpiB is able to isomerize ribose-5-phosphate, its primary role is the interconversion of D-allose-6-phosphate and D-allulose-6-phosphate (Roos et al., 2008) . It is thus probable that the LacAB enzyme of S. agalactiae has also this activity. If we consider that D-allose is a substrate of PTS
Fru2
, it should also be possible that D-ribose is transported by PTS
. Indeed, the configuration of D-ribose is structurally analogous to that of D-allose, and it was found that the E. coli ABC transporter of D-allose is also partly responsible for the transport of D-ribose (Kim et al., 1997; Poulsen et al., 1999 Number of bacteria ) was cloned upstream of a bgalactosidase gene in the promoter probe plasmid pTCV-lacZ. S. agalactiae strain A909 transformed by this construction was incubated at 378C without agitation in a chemically defined medium without any carbohydrate ( ), with human amniotic fluid ( ), or with human cerebrospinal fluid (). After 6 h, 12 h, 24 h, or 48 h of incubation bacteria were harvested and the b-galactosidase activity was measured. Mean activities with standard deviation from at least three independent experiments are presented (Panel B). Number of bacteria in the inoculum and after 6 h, 12 h, 24 h, or 48 h of incubation are given in panel A. Table 1 ). The impact of the modification of these two amino acids on the activity of the fru 2 promoter was finally tested by measuring the bgalactosidase activity in each of these strains. In the presence of D-glucose as the only carbohydrate source in the growth medium, the fru 2 promoter is inactive (Table 1) . However, the alanine substitution of the histidine at position 67 in EIIA Fru2 (EIIA ) increased the bgalactosidase activity of the strain by a factor 367 (Fig.  6A ). The alanine substitution of the cysteine at position 9 in EIIB Fru2 (EIIB ) and substitions in both EIIA (EIIA- ) and EIIB (EIIB ) have no impact on the activity of the fru 2 promoter (Fig. 6A ).
In the absence of D-glucose and in presence of D-ribose in the growth medium, the fru 2 promoter is active (Table 1 ). The alanine substitution of the histidine at position 67 in EIIA Fru2 (EIIA ) increased the bgalactosidase activity of the strain by a factor 21 ( ) was cloned upstream of a bgalactosidase gene in the promoter probe plasmid pTCV-lacZ, and introduced in the S. agalactiae A909 wild-type strain (WT), the deletion mutant of the EIIC Fru2 gene (Dfru 2 EIIC), the deletion mutant of the PTS Fru2 genes (Dfru 2 PTS), and the complemented strain (Dfru 2 PTS::fru 2 PTS). Strains were incubated during 48 h at 378C without agitation in a chemically defined medium without any carbohydrate ( ), with 5 mM D-ribose ( ), or with 5 mM D-allose (). Bacteria were then harvested and the b-galactosidase activity was measured. Mean activities with standard deviation from at least three independent experiments are presented. ) and substitions in both EIIA (EIIA ) and EIIB (EIIB ) strongly reduced the b-galactosidase activity of the strain (Fig. 6B) .
These results indicate that the EIIA and EIIB subunits of PTS Fru2 are involved in the activation of the fru 2 promoter, and that the histidine-67 and cysteine-9 of these proteins are important for this function respectively.
Localization of the promoter of the fru 2 operon
To localize the promoter of the fru 2 operon, total RNAs were purified from strain A909 cultured in CDM containing 
Involvement of Fru 2 R in the activation of the fru 2 operon
By a search for conserved domain on the NCBI website, we found that Fru 2 R possesses several motifs characteristic of PRD-activators: a) a deoR-type helix-turn-helix motif allowing the fixation of proteins to DNA (pfam08279:HTH_11; amino acids 8-58), a PRD 2 motif (pfam00874; amino acids 298-384) which could be phosphorylated by the PTS system in response to carbon source, a PTS-IIB fold (cl10014; amino acids 395-471) found in cellobiose/lichenan, ascorbate, lactose, galactitol, mannitol and Bgl PTS system, and a PTS-IIA motif specific of fructose/mannitol IIA PTS (cd00211, amino acids 498-625) (Stulke et al., 1998; Joyet et al., 2013; Marchler-Bauer et al., 2015) . This search did not revealed the PRD 1 domain that is also characteristic of PRD-activators because Fru 2 R lacks the important H6aa-R motif of this domain (Greenberg et al., 2002) . However, the alignment of the amino sequences of FrzR (EMBL Acc. n8 C5J5A2) of E. coli (which contains the PRD 1 domain) and Fru 2 R allowed us to delimitate a putative PRD 1 domain between amino acids 193 and 280 of Fru 2 R.
To confirm the role of Fru 2 R presumed by the in silico analysis, we first deleted the entire fru 2 R gene from the chromosome of strain A909. After transformation with pTCV-fru 2 IR 317 ::lacZ, wild-type and Dfru 2 R strains were grown in CDM containing 30 mM D-ribose upon the entry into the stationary phase of growth. The activity of the fru 2 promoter was then estimated by measuring the b-galactosidase activity in both strains. In the deletion mutant, the b-galactosidase activity was reduced by a factor 627 with respect to that of the wild-type strain. The reintroduction of the fru 2 R gene in the chromosome of the Dfru 2 R strain restored the wild-type level of bgalactosidase activity, confirming the role of Fru 2 R as an activator of the fru 2 operon (Fig. 7) .
By a gel shift assay, we secondly proved that Fru 2 R interacts with the 184 bp right end of the intergenic region (fru 2 IR 184 ) upstream of the fru 2 operon (Fig. 8 ). This DNA region contains the identified palindromic sequences sites 1 and 2, the 235 and 210 boxes of the promoter, the transcription start, and the ribosome binding site of the fru 2 operon (Fig. 1) .
Identification of histidine and cysteine residues affecting the function of Fru 2 R In view of identifying putatively phosphorylatable residues in the PRD 1 , PRD 2 , EIIB and EIIA domains that could ) was cloned upstream of a bgalactosidase gene in the promoter probe plasmid pTCV-lacZ, and introduced in the S. agalactiae A909 wild-type strain (WT), the mutant deleted of the fru 2 R gene (Dfru 2 R), and the complemented strain (Dfru 2 R::fru 2 R). Strains were grown in a chemically defined medium containing 30 mM D-ribose to the entry into the stationary phase of growth. The activity of the fru 2 promoter was estimated by measuring the b-galactosidase activity in each strain. Mean values with standard deviation from at least three independent experiments are presented. affect the function of Fru 2 R, we aligned the amino acid sequences of Fru 2 R with those of three other members of the FrzR/MtlR family: FrzR of E. coli (EMBL Acc. n8 CAR92511.1), FrzR of L. monocytogenes (EMBL Acc. n8 AEO07123.1.) and MtlR of B. subtilis (EMBL Acc. n8CAB12223.1). We noticed the presence of an histidine at position 323 in the PRD 2 domain and of a cysteine at position 400 in the EIIB-like domain of Fru 2 R that are conserved in the PRD-activators of the three other species. A histidine at position 549 in the EIIA-like motif of Fru 2 R is also conserved between the PRD-activators of S. agalactiae and B. subtilis. This latter histidine is not present in FrzR of E. coli and L. monocytogenes because they do not possess an EIIA-like motif.
These histidine and cysteine residues, as also the histidine at positions 230 and 243 in the putative PRD 1 domain, were substituted by site-directed mutagenesis either into an unphosphorylatable amino acid (alanine) or into a phosphorylatable amino acid (serine) (Fig. 9) . The wild-type copy of fru 2 R was then replaced in the same chomosomic position by each of the different mutated allele. Each of these strains were afterwards transformed by pTCV-fru 2 IR 317 ::lacZ and cultured until the entry of the stationary phase of growth in CDM containing 30 mM D-ribose (inducing carbohydrate for the wild-type strain, Table 1 ) or 15 mM D-glucose (non inducing carbohydrate for the wild-type strain, Table 1 ). To estimate the impact of the modification of these amino acids on the function of Fru 2 R, we then compared the activity of the fru 2 R promoter by measuring the b-galactosidase activity in each of these strains. The 184 bp right end of the intergenic region (IR 184 ) of the fru 2 operon was amplified by PCR and end-labeled with digoxigenin-11-ddUTP. The labeled DNA (0.8 ng) was then incubated (lanes 2A-4A and lanes 2B-5B) or not (lanes 1A and 1B) with purified Fru 2 R [lanes 2A, 2B and 4A (250 ng); lanes 3A and 3B (500 ng); lane 4B (750 ng), lane 5B (1000 ng)]. In lane 4A, the labeled DNA was also incubated with a 100-fold excess of the unlabeled IR 184 fragement. As a control the 181 bp upstream intergenic region of rbsR was also amplified by PCR and end-labeled with digoxigenin-11-ddUTP. The labeled rbsR DNA (0.8 ng) was then incubated [lane 7B (250 ng); lane 8B (500 ng); lane 9B (750 ng), and lane 10B (1000 ng)] or not (lane 6B) with purified Fru 2 R. Samples were electrophoresed in a polyacrylamide gel, transfer to a nylon membrane and incubated with adequate antibodies. Chemiluminescent DNA fragments were revealed by exposition to an X-ray film. In the presence of D-glucose as the only carbohydrate source in the growth medium, Fru 2 R is unable to activate the fru 2 promoter (Table 1) . However, the alanine substitution of the cysteine at position 400 in the EIIBlike motif (Fru 2 R C400A ) or of the histidine at position 549 in the EIIA-like motif (Fru 2 R H549A ) increased the bgalactosidase activity of the strain by a factor 12 or 52 respectively (Fig. 9A ). In the absence of D-glucose and in presence of D-ribose in the growth medium, Fru 2 R is able to activate the fru 2 promoter (Table 1 ). The alanine substitution of the cysteine at position 400 (Fru 2 R C400A ) or of the histidine at position 549 (Fru 2 R H549A ) increased slightly this activation (by a factor 3.5) (Fig. 9B) . Nevertheless, the alanine substitution of the histidine at position 243 in the PRD 1 motif (Fru 2 R H243A ) or of the histidine at position 323 in the PRD 2 motif (Fru 2 R H323A )
reduces the b-galactosidase activity of the strain by a factor 35 or 70 respectively (Fig. 9B) . Finally, the serine substitution of the cysteine at position 400 in the EIIB-like domain or the alanine substitution of the histidine at position 230 in the PRD 1 motif has no significant impact on the function of Fru 2 R, either in the presence of D-glucose or of D-ribose in the growth medium ( Fig. 9A and B) . These results indicate that Fru 2 R is involved in the activation of the fru 2 promoter and that the histidine-243 (PRD 1 domain), histidine-323 (PRD 2 domain), cysteine-400 (EIIB-like domain), and histidine-549 (EIIA-like domain) are important for this function. The importance of phosphorylation on the activity of Fru 2 R was verified in a DptsI mutant transformed by pTCV-lacZ::fru 2 IR 317 .
In this mutant, none of the phosphorylatable amino acids of HPr, PTS Fru2 and Fru 2 R will become phosphorylated. After 48 h of incubation in the presence of glucose or ribose, the b-galactosidase activity produced by this mutant was found to be negligible (Fig. 10) .
Interaction of EIIB Fru2 with Fru 2 R and EIIA
Fru2
As we determined that EIIA
, EIIB Fru2 , and Fru 2 R are important for the activation of the fru 2 operon, we searched if these proteins were able to interact physically. For that aim, we used a bacterial two-hybrid assay in which the interaction of two partners fused to the T18 and the T25 fragments of the adenylate cyclase induces a b-galactosidase activity. We thus found that the coexpression of the EIIB Fru2 fusion protein with the complete Fru 2 R, the C-terminal end of Fru 2 R expressing the EIIB-like and EIIA-like motifs, or the EIIA Fru2 fusion proteins induced a b-galactosidase activity of 18 and 48 arbitrary units respectively. All control interactions induced an activity of less than 1 arbitrary units (Fig.  11) . These results indicate that EIIB Fru2 interacts physically with the C-terminal part of Fru 2 R (expressing the EIIBlike and EIIA-like motifs) and with EIIA Fru2 .
Discussion
We previously identified the presence of the fru 2 metabolic operon on a genomic island of S. agalactiae (Patron et al., 2015) . The role of all proteins encoded by this operon can be connected in two metabolic pathaways: the D-allose degradation pathway and the nonoxidative branch of the pentose phosphate pathway. Both pathways are linked at the level of D-fructose-6- ::lacZ and incubated during 48 h at 378C without agitation in a chemically defined medium containing 15 mM D-glucose (A) or 30 mM D-ribose (B). The growth of the DptsI mutant was strongly affected in the CDM-ribose medium (OD 600 at 48 h of 0.18 and 0.4 for the mutant and wild-type strains, respectively) but not in the CDM-glucose medium (OD 600 at 48 h of 0.5 and 0.8 for the mutant and wild-type strains respectively). The activity of the fru 2 promoter was estimated by measuring the b-galactosidase activity in each strain. Mean values with standard deviation are presented. phosphate production (Fig. 4) . The pentose phosphate pathway is (i) one of the three essential pathways of central metabolism, (ii) an alternative way of oxidizing glucose, and (iii) involved in the conversion of hexose to pentose (Willey et al., 2013) . We demonstrated that two sugars belonging to these pathways (D-allose and Dribose) are necessary to strongly activate the fru 2 promoter and that PTS Fru2 and Fru 2 R are necessary for this activation (Figs 2 and 529 ). D-allose is an aldohexose found in limited quantities in natural products. Dallose is metabolized by some bacteria, such as Aerobacter aerogenes and E. coli (Kim et al., 1997; Poulsen et al., 1999) . A. aerogenes, converts D-allose to D-fructose-6-phosphate by inducible enzymes via D-allose-6-phosphate and D-allulose-6-phosphate intermediates (Gibbins and Simpson, 1964; Mortlock, 1976) . Poulsen and collaborators demonstrated that E. coli is able to use D-allose as a carbon source through the D-allose permease (Poulsen et al., 1999) . This permease is an ABC-transporter that is also able to transport D-ribose with a low affinity. D-allose and D-ribose transport systems are functionally redundant because D-ribose exists primarily as a pyranose form (80%) in solution, a configuration that is analogous to that of D-allose, except that the latter has a CH 2 OH group bound to C5 (Mowbray and Cole, 1992) . D-allose binds also to the ribosebinding protein (RBP) with a low affinity (1000 times less than ribose), but sufficient to elicit chemotaxis (Aksamit and Koshland, 1974, Spudich and Koshland, 1975) . In the genome of S. agalactiae A909, three genes (sak0166, sak0167, and sak0168) are annotated as D-ribose ABC transporter but no transporter of Dallose has been identified before our study. It is highly probable that PTS Fru2 is the main transporter of D-allose in S. agalactiae and that it also transports D-ribose with a lower affinity due to a configuration that is analogous to that of D-allose. To our knowledge, this is the first description of a PTS transporter for D-allose and Dribose.
The fru 2 transcriptional promoter is also active when S. agalactiae is incubated in human cerebrospinal or amniotic fluids and in complex culture media, such as Todd Hewitt broth or Brain-Heart Infusion (Figs 2 and 3). As reported by the Human Metabolome Database, D-ribose and D-allose are present in the human cerebrospinal fluid (D-ribose at a concentration of 2.5 mM, Dallose at an unquantified concentration; http://www. hmdb.ca/). Altough we were unable to find the complete sugar composition of the human amniotic fluid and of the two used complex culture media, it is probable that they contain a sufficient concentration of D-allose and/or D-ribose to allow the activation of the fru 2 promoter. In particular D-ribose was detected in numerous human biological fluids and tissues (http://www.hmdb.ca/). It should thus also be present in the human amniotic fluid and in the undefined animal and yeast digestion products present in the two complex culture media.
We demonstrated that Fru 2 R, a PRDs-containing transcriptional regulator belonging to the DeoR family, is necessary to activate the fru 2 promoter (Figs 7 and 9 ). Fru 2 R is able to bind to the intergenic region of the fru 2 operon (Fig. 8) . PRDs-containing transcriptional activators generally interact with a palindromic sequence located up to 100 bp upstream from the transcriptional start site . Two palindromic sequences located in the 113 bp upstream the transcriptional start site of the fru 2 operon were identified (Fig. 1) . The palindromic site 2 contains the putative minus 235 box of the promoter (Fig. 1) . Fru 2 R might interact with these palindromic sites, and particularly with site 2 to facilitate the binding of the RNA polymerase holoenzyme to the promoter, and allowing the transcription of the fru 2 operon.
For many PRDs-containing regulators, protein multimerization and activity are altered by phosphorylation of specific histidine or cysteine residues. We showed that histidine-323 in PRD 2 (Fig. 9) . These modifications have an inhibitory impact on the activity of Fru 2 R, suggesting that the phosphorylation of these amino acids affects positively the function of the activator. However, the histidine-243 in PRD 1 does not correspond to a conserved phosphorylatable histidine in other MtlR-like proteins. At this stage, it can thus not be excluded that the low activity of the Fru 2 R mutant with the His243Ala replacement is the consequence of structural changes in Fru 2 R. On the contrary, the replacement by an alanine of the histidine-549 in the EIIA-like domain has an activatory impact on the activity of Fru 2 R, suggesting that the phosphorylation of this amino acid affects negatively the function of the activator. The Cys400Ala replacement in the EIIB-like domain has probably only a minor inhibiting effect, because in glucose-grown cells Fru 2 R C400A was only eightfold more active than the wildtype protein and fourfold less active than Fru 2 R H549A ( Fig. 9 ). Our data are quite reminiscent of the results obtained with MtlR of B. subtilis. In MtlR, an activatory phosphorylation site was identified in the PRD 2 domain (on the conserved histidine positioned at amino acid 342 of MtlR), which becomes phosphorylated by the cognate P-HPr. Two inhibitory phosphorylation sites are also present in MtlR (i) in the EIIB-like domain (on the conserved cysteine positioned at amino acid 419 of MtlR), which becomes phosphorylated by P-EIIA Mtl , and
(ii) in the EIIA-like domain (on the conserved histidine positioned at amino acid 599 in MtlR), which becomes phosphorylated by P-EIIB Mtl (Joyet et al., 2010 promoter. This regulatory function is affected by the alanine replacement of the histidine-67 of EIIA Fru2 or of the cysteine-9 of EIIB Fru2 (Fig. 6 ). The replacement of the histidine-67 of EIIA Fru2 by an alanine has an activatory impact on its activity, suggesting that the phosphorylation of this amino acid affects negatively its function. On the contrary, the replacement of the cysteine-9 of EIIBFru2 by an alanine has an inhibitory impact on its activity (Fig. 6) . We found that EIIB Fru2 interacts with the two Cterminal domains (EIIB-like and EIIA-like) of Fru 2 R (Fig.  11) (Fig. 6 and illustration of Fig. 12 ). This form is unphosphorylated at H243 and H323 but phosphorylated at C400 and H549. It binds unphosphorylated EIIB Fru2 .
From the above data and those concerning other MtlR-like regulators, we propose a model of regulation of the fru 2 operon by Fru 2 R and the PTS Fru2 , in the presence or in the absence of an activatory carbohydrate in the growth medium ( Fig. 12 ; Henstra et al., 2000; Joyet et al., 2010; Z ebr e et al., 2015) .
In the presence of D-glucose as the only carbohydrate source, the fru 2 promoter is very slightly active (Table 1, Figs (5 and 6)A, and 9A). In the presence of D-glucose, EIIA Fru2 should be phosphorylated on the histidine-67, EIIB Fru2 should be phosphorylated on the cysteine-9, and Fru 2 R should be phosphorylated on the histidine-549 of the EIIA-like motif and on the cysteine-400 of the EIIB-like motif (although at a lower level than at the EIIA-like motif) (Figs 6A and 9A) . We propose that the phosphorylated form of EIIB Fru2 is unable to bind the C-terminal part of Fru 2 R but is still able to phosphorylate it. In the presence of an efficient metabolizable sugar, such as glucose, HPr is phosphorylated by a kinase on the specific serine-46, and is barely phosphorylated on histidine-15 (G€ orke and St€ ulke, 2008 . The phosphorylation cascade going from P-H15-HPr to P-EIIB Fru2-C9 , via P-EIIA , would then be redirected towards Fru 2 R, which would be slightly phosphorylated on its cysteine-400 by P-EIIA Fru2 and on its histidine-549 by P-EIIB Fru2 : This inactive form of Fru 2 R should be in equilibrium with the completely unphosphorylated and also inactive forms and with very few amount of the active form that allows a background transcription level of the fru 2 operon. When only D-ribose is present (B), there is no activity of other efficient PTSs, and P-H15-HPr should accumulate into the bacteria. This would allow P-H15-HPr to phosphorylate Fru 2 R on its histidine-243 (PRD 1 ) and histidine-323 (PRD 2 ) activatory phosphorylation sites. In this condition, a phosphorylation cascade going from P-H15-HPr, via P-EIIA Fru2-H67 and P-EIIB , would also allow the entry of D-ribose through the EIIC Fru2 porter. During its transport into the bacteria D-ribose would be phosphorylated on carbon-5 by P-EIIB . This phosphorylation cascade would prevent EIIA Fru2 to phosphorylate Fru 2 R on its C400 phosphorylation site but would also allow the binding of the unphosphorylated form of EIIB Fru2 to the EIIAlike motif of Fru 2 R and the activation of Fru 2 R. Dotted arrow, low efficiency; Solid arrow, high efficiency.
The fru 2 metabolic operon of S. agalactiae 689 Joyet et al., 2010; . This inactive form of Fru 2 R should be in equilibrium with the completely unphosphorylated and also inactive forms and with very few amount of the active form, that allows a background transcription level of the fru 2 operon (Fig. 12A) .
In the presence of D-ribose as the only carbohydrate source, the fru 2 promoter is active ( interacts with the C-terminal part of Fru 2 R, iii) Fru 2 R should be mostly dephosphorylated on the cysteine-400 of the EIIB-like motif (3.4 more dephosphorylated than in the presence of D-glucose) and on the histidine-549 of the EIIA-like motif (14.9 more dephosphorylated than in the presence of D-glucose), iv) Fru 2 R should be phosphorylated on its histidine-323 (PRD 2 ) and maybe also on its histidine-243 (PRD 1 ) (Figs 6B and 9B). The mutations made on other phosphorylatable amino acids have no effect on the transcription of the fru 2 operon. The phosphorylation level of H15-HPr is dependent on the rate of uptake of all efficient PTS carbohydrates. When D-ribose is only present, there is no activity of other efficient PTSs, and P-H15-HPr should accumulate into the bacteria. This would allow P-H15-HPr to phosphorylate Fru 2 R on its histidine-243 (PRD 1 ) and histidine-323 (PRD 2 ) activatory phosphorylation sites, as it was reported for MtlR of B. subtilis (Henstra et al., 2000; Joyet et al., 2010) . The accumulation of P-His15-HPr would also boost the phosphorylation cascade going from P-His15-HPr, via P-EIIA Fru2-H67 and P-EIIB This binding will mask the phosphorylatable His-549 and activate Fru 2 R. Under the conditions described above, Fru 2 R would be able to interact with the fru 2 intergenic region and the fru 2 promoter would be active (Fig. 12B) . This model could be a basis for the design of new experiments aiming to elucidate the detailed mechanism by which the fru 2 operon is regulated.
Experimental procedures
Plasmids, bacterial strains, and growth conditions Plasmids and bacterial strains used in this study are listed in Table 2 . E. coli strains were routinely grown in LB broth (MP, Solon, USA; Cat. n8 1005317) at 378C with agitation or on LB-agar plate (1.5% agar). S. agalactiae strains were routinely grown in Todd Hewitt (TH) broth (Sigma-Aldrich, St-Louis, Mo; Cat. n8 T1438) at 378C without agitation and on TH-agar or Brain Heart Infusion-agar (BHI-agar) (AES, Bruz, France, Cat. n8 EAB140102). When necessary, E. coli and S. agalactiae strains were grown with ampicillin (100 mg ml 21 ), erythromycin (150 mg ml 21 for E. coli or 10 mg ml 21 for S. agalactiae) or kanamycin (25 mg ml 21 or 50 mg ml 21 for E. coli). S. agalactiae were also cultured in a liquid chemically defined medium (CDM) or on CDM-1.5% agar plates containing one or more added carbohydrates. All CDM components were from Sigma-Aldrich (St-Louis, Mo) (Moulin et al., 2016) .
Chromosomal and plasmidic DNA purification
Chromosomal DNA of S. agalactiae cultured overnight without agitation in TH broth was purified by the phenol/chloroform method (Green and Sambrook, 2012) . The DNA concentration was measured with a NanoDrop Lite Spectrophotomer (Thermo scientificV R ) the ratio of absorbance at 260 nm and 280 nm was used to assess its purity. E. coli plasmids were purified with a NucleoSpin V R Plasmid kit (Macherey-Nagel V R ), according to the manufacturer's instructions.
Polymerase chain reaction (PCR)
Polymerase chain reactions were performed with a 3 Prime Thermal Cycler (Techne V R ) using Q5 V R High-Fidelity DNA polymerase (NEB V R ). The resulting PCR fragments were purified with a NucleoSpin V R Gel and PCR clean-up kit (MachereyNagel V R ), according to the manufacturer's instructions.
Rapid amplification of 5 0 -cDNA-ends by polymerase chain reaction (5 0 -RACE PCR) S. agalactiae A909 was grown during 3 h in CDM supplemented with 30 mM D-ribose. Total RNAs of growing cells were extracted as described by Lamy et al. (2004) , and the 5 0 -end of the fru 2 operon mRNA was determined using the 5 0 /3 0 rapid amplification of cDNA ends PCR second generation kit (Roche Applied Science). Three fru 2 R antisense specific primers (275R, 276R and 277R) were designed (Table 2 ) to produce cDNAs. Control RT-PCRs, omitting reverse transcriptase, were performed to check for DNA contamination of the RNA preparation (Table 3) .
DNA sequencing
PCR products purified with the NucleoSEQ V R kit (MachereyNagel V R ) were sequenced on both strands using the Big Dye Terminator v3.1 cycle sequencing kit from Applied Biosystems and the ABI Prism 310 Genetic Analyzer.
Electroporation
Electrocompetent E.coli and S. agalactiae strains were produced as described by Dower et al. (1988) and Ricci et al. 1994) . E. coli and S. agalactiae were then transformed by electroporation using the Micropulser TM apparatus (Biorad V R ) and the Ec2 conditions (2.5 kV) with 1-2 mg of appropriate plasmids respectively. Transformants were selected on LBagar (E. coli) or TH-agar (S. agalactiae) plates, with the appropriate antibiotics.
Construction of fru 2 R, fru 2 PTS, fru 2 EIIC and ptsI deletion mutants S. agalactiae A909Dfru 2 R is a non polar mutant of strain A909 deleted of the entire coding sequence of fru 2 R by allelic exchange. Upstream and downstream regions of fru 2 R were amplified by PCR with primers 13F/14R and 15F/16R respectively. A recombination cassette, consisting of a fusion between these two regions was obtained using splicing-by-overlap-extension PCR with primers 13F and 16R (Table 3) . To carry out chromosomal gene inactivation, appropriate PCR fragments (overlap-extension) were hydrolysed by Kpnl and BamHI, and cloned into the KpnI/BamHI sites of the thermosensitive shuttle plasmid pG 1 host1 (Biswas et al., 1993) . The recombinant plasmid was electropored in E. coli for amplification, purified and then electropored in strain A909. Allelic exchange was performed as described by Biswas et al. (1993) . Deletion of fru 2 R was confirmed by PCR and sequencing. To complement this mutant, the entire coding sequence of fru 2 R was amplified by PCR with primers 13F and 16R and inserted in pG 1 host1, as described above. After allelic exchange, the complementation of fru 2 R was confirmed by PCR and sequencing.
S. agalactiae A909Dfru 2 PTS is a non polar mutant of strain A909 deleted of the entire coding sequence of fru 2 PTS (EIIA Fru2 , EIIB Fru2 and EIIC
Fru2
) by allelic exchange. Upstream and downstream regions of fru 2 PTS were amplified by PCR with primers 54R, 55F and 56R, 57F respectively. A recombination cassette, consisting of a fusion between these two regions was obtained using splicing-by-overlap-extension PCR with primers 57F and 54R (Table 3) . To carry out chromosomal gene inactivation, appropriate PCR fragments (overlap-extension) were hydrolysed by Kpnl and BamHI, and cloned into the KpnI/BamHI sites of the thermosensitive shuttle plasmid pG 1 host1. The recombinant plasmid was electropored in strain A909 and allelic exchange was performed as described by Biswas et al. (1993) . Deletion of fru 2 PTS was confirmed by PCR and sequencing. To complemente this mutant the entire coding sequence of fru 2 PTS was amplified by PCR with primers 54R and 57F and inserted in pG 1 host1, as described above. The recombinant plasmid was electropored in strain A909Dfru 2 PTS. After allelic exchange, complementation of fru 2 PTS was confirmed by PCR and sequencing.
S. agalactiae A909Dfru 2 EIIC is a non polar mutant of strain A909 deleted of the entire coding sequence of fru 2 EIIC by allelic exchange. Upstream and downstream regions of fru 2 EIIC were amplified by PCR with primers 388F, 389R and 390F, 391R respectively. A recombination cassette, consisting of a fusion between these two regions was obtained using splicing-by-overlap-extension PCR with primers 388F and 391R (Table 3) . To carry out chromosomal gene inactivation, appropriate PCR fragments (overlap-extension) were hydrolized by Kpnl and BamHI, and cloned into the KpnI/BamHI sites of pG 1 host1. The recombinant plasmid was electropored in strain A909 and allelic exchange was performed as described by Biswas et al. (1993) . Deletion of fru 2 EIIC was confirmed by PCR and sequencing. To complement this mutant, the entire coding sequence of fru 2 EIIC was amplified by PCR with primers 388F and 391R and inserted in pG 1 host1, as described above. The recombinant plasmid was electropored in strain A909Dfru 2 EIIC. After allelic exchange, complementation of fru 2 EIIC was confirmed by PCR and sequencing.
S. agalactiae A909DptsI is a non polar mutant of strain A909 deleted of nt 407-1728 by allelic exchange. The upstream region of ptsI (sak0946) was amplified with the mutagenic primers 207F and 208R (Table 3 ). The downstream region was amplified with primers 209F and 210R (Table 3) . A fusion between these two regions was obtained after restriction with Bsal and ligation. To carry out chromosomal gene inactivation, the resulting fusion was reamplified using 207F and 210R, hydrolized by BamHI and EcoRI, and cloned into the BamHI/EcoRI sites of pG 1 host1. The recombinant plasmid was electropored in strain A909 and allelic exchange was performed as described by Biswas et al. (1993) . Deletion of ptsI was confirmed by PCR and sequencing.
Site-directed mutagenesis of Fru 2 R, EIIA Fru2 , and EIIB
Some putatively phosphorylatable His and Cys residues of Fru 2 R were substituted by Ala or Ser to generate unphosphorylatable or phosphorylatable Fru 2 R variants. Mutagenic primers 311F/312R, 263F/310R, 244F/245R, 265F/266R, (Table 3) . These fragments served as template for an additional PCR with the 355F and 356R primers. Resulting amplified fragments were inserted into the BamHI/EcoRI restriction site of the pG 1 host1 vector. The presence of the desired mutation and the absence of secondary mutations were confirmed by DNA sequencing.
b-galactosidase transcriptional fusion assays
Plasmid pTCV-lacZ (Poyart and Trieu-Cuot, 1997 ) was used to construct transcriptional fusions between the E. coli lacZ reporter gene and upstream regions of the fru 2 operon. The entire intergenic region (IR 540 ) or its 317 bp right end (IR 317 ) were amplified by PCR using oligonucleotides 155F and 153R (possesing a SmaI or a BamHI restriction site, respectively) or 154F and 153R (possesing an EcoRI or a BamHI restriction site, respectively) respectively. The corresponding purified DNA fragments were then hydrolysed with SmaI and BamHI or by EcoRI and BamHI and cloned in the pTCV-lacZ vector previously hydrolysed by the same restriction enzymes.
For qualitative assays of induction of the fru 2 promoter, S. agalactiae A909 transformed by the above constructed plasmids were grown during 48 h at 378C on plates containing TH-agar, BHI-agar, CDM-agar containing various carbohydrates or on agar-plates containing a 1V/1V mix of CDM and human biological fluids (amniotic fluid or cerebrospinal fluid, all obtained from the University Hospital Bretonneau, Tours, France). All plates contained also 60 lg ml 21 5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside (X-Gal) and 10 mg ml 21 erythromycin. In the absence of induction of the fru 2 promoter white colonies were formed, whereas blue colonies appeared after induction of this promoter.
For quantification of the induction of the fru 2 promoter in complex medium, TH broth containing 10 lg ml 21 erythromycin was inoculated to an OD 600 nm of 0.05 with an overnight culture in the same medium of strain A909 containing the above constructed plasmids. This culture was incubated at 378C during 72 h without agitation. Bacteria were harvested at different times and stored at 2208C until the b-galactosidase assay.
For quantification of the induction of the fru 2 promoter in human biological fluids, CDM containing 15 mM D-glucose and 10 lg ml 21 erythromycin was inoculated to an OD 600 nm of 0.05 with an overnight culture (in TH broth containing 10 lg ml 21 erythromycin) of strain A909 transformed by the above constructed plasmids. This culture was incubated at 378C without agitation to the midexponential phase of growth. Bacteria were then centrifuged, washed three times with CDM without glucose and incubated during 48 h in a 1V/1V mix of CDM without glucose and human cerebrospinal or amniotic fluids. Bacteria were harvested at different times and stored at 2208C, until the b-galactosidase assay.
To quantitatively compare the induction of the fru 2 promoter by D-ribose or D-allose CDM vials containing 10 mg ml 21 erythromycin and 15 mM glucose were inoculated to an OD 600 nm of 0.05 with an overnight culture in the same medium of strains A909 (pTCV-fru 2 IR 317 ::lacZ), A909Dfru 2 PTS (pTCVfru 2 IR 317 ::lacZ) or A909Dfru 2 PTS::fru 2 PTS (pTCV-fru 2 IR 317 ::-lacZ). These cultures were incubated at 378C without agitation until the entry of the stationary growth phase. Bacteria were then washed three times with CDM and incubated during 48 h at the same density in CDM containing 5 mM D-allose, 5 mM D-ribose or with no carbohydrate. After this incubation, bacteria were harvested and stored at 2208C, until the b-galactosidase assay.
For b-galactosidase assays, pelleted bacteria (10 ml of the above cultures) were suspended in 500 ml of the Z buffer of Miller and lysed mechanically with glass beads in a FastPrep V R 224 instrument (Miller, 1972) . Cell debris was eliminated by centrifugation (5 min; 8000 g). To reflect bacterial density, the protein content of the supernatants were estimated by measuring the absorption at 595 nm (A 595 ) obtained after 5 min incubation of 20 ll of the supernatants with 980 ll of a 1/5 dilution of the Bio-Rad protein assay dye reagent concentrate (BioRad, Hercules, CA). Supernatants were then incubated with 0.5 mgÁml 21 DNase I (New England BioLabs V R ) at 378C for 30 min. After the addition of 200 ll of 4 mg ml 21 o-nitrophenyl-b-D-galactopyranoside in Z buffer (pH 7), the change of the absorption at 420 nm (A 420 ) was measured according to the time. bgalactosidase activity was expressed in arbitrary unit, using the following formula: (1000 Á V 1 Á A 420 )/(V 2 Á t Á A 595 ), with V 1 , the volume of the sample that was added to the reaction mixture for b-galactosidase in milliliters; V 2 , volume of the sample that was added to the reaction mixture in milliliters; t, time of the reaction in minutes. All experiments were carried out in triplicate.
Purification of His-tagged Fru 2 R. The fru 2 R gene (sak1762) was amplified by PCR with primers 272F and 183R (Table 2) . PCR products were hydrolized by BamHI and EcoRI and cloned into the BamHI/EcoRI restriction sites of the pET28a vector (EMD Biosciences). After sequencing, recombinant vectors were electroporated in E. coli BL211 strain. Bacteria were grown at 378C in LB medium with shaking, and the expression of His-tagged Fru 2 R was subsequently induced by the addition of 1 mM IPTG. The culture was further incubated with shaking at 378C for 5 h. Bacteria were harvested by centrifugation and stored at 2808C. Recombinant Fru 2 R-His tagged protein was purified under native conditions by affinity chromatography on nickel-nitrilotriacetic acid columns, according to the manufacturer's recommendations (Sigma-AldrichV R ). For purity estimation, recombinant Fru 2 R proteins were electrophoresed on a sodium dodecyl sulfate-polyacrylamide gel (SDS-PAGE) and colored with Coomassie blue, as described by Laemmli (1970) .
Electrophoretic mobility shift assay
The 184 bp right part of the upstream intergenic region of fru 2 R was amplified by PCR using primers 243F and 154R (Table 3) . As a control, a 181 bp ustream intergenic region of the rbsR gene (sak 0171) was also amplified by PCR using primers 324F and 323R (Table 3 ). The amplified DNA fragment was end-labeled with digoxigenin-11-ddUTP and incubated with purified Fru 2 R, according to the instructions of the manufacturer of the Dig Gel Shift Kit, 2nd generation (Roche V R ). The resulting DNA-protein complexes were loaded onto a 6% polyacrylamide gel, transfered by capillarity to a positively charged nylon membrane (Boehringer Mannheim), and incubated with anti-digoxigenin conjugated antibodies conjugated with alcaline phosphatase. Chemiluminescent DNA fragments were revealed after exposition to an X-ray film (Hyperfilm TM ECL TM , Amersham).
Bacterial two-hybrid assays
Nucleotide sequences coding for Fru 2 R, the C-terminal end of Fru 2 R expressing the EIIB-like and EIIA-like motifs (Fru 2 R EIIB-EIIA ), EIIA Fru2 and EIIB Fru2 of strain A909 were amplified by PCR using primers 294F/395R, 339F/395R, 371F/368R, or 299F/300R respectively (Table 3) . They were then hydrolysed with Pstl and EcoRI, and cloned between the corresponding restriction sites of pUT18C or pKT25 vectors . The resulting recombinant plasmids expressed hybrid proteins, in which the protein of interest is either fused to the C-terminus of the T18 fragment or to the C-terminus of the T25 fragment of adenylate cyclase respectively. Each recombinant plasmid was transformed in E. coli XL1-blue. Transformants were plated on LB containing 100 mg ml 21 ampicillin (pUT18C derivatives) or 50 mg ml 21 kanamycin (pKT25 derivatives). Recombinant vectors were verified by DNA sequencing.
For two-hybrid assays, recombinant vectors (pKT25 and pUT18C) carrying the S. agalactiae genes under study were cotransformed in the desired combinations into E. coli DHT1 cells (Dautin et al., 2000) . For qualitative assays, cotransformed E. coli DHT1 bacteria were grown on LB agar supplemented with 100 mg ml 21 ampicillin, 50 mg ml 21 kanamycin, and 60 mg ml 21 X-Gal. The plates were incubated for 24-48 h at 308C. Blue colonies appear when the recombinant proteins expressed by pKT25 and pUTC18C interact. The efficiency of these interactions was quantified by measuring the b-galactosidase activities. For that aim, bacteria were grown at 308C in LB broth containing kanamycin and ampicillin until mid-exponential phase of growth. Cells were then harvested by centrifugation and stored at 2208C, until the assay. b-galactosidase assays were carried out as described in the transcriptional fusion assays section.
